Rucaparib 300 mg Tablets

Get a Price/Quote

MOQ : 100 Packs

Rucaparib 300 mg Tablets Specification

Salt Composition
Rucaparib 300 mg

Indication
Used for the treatment of ovarian cancer and certain other cancers

Dosage Form
Tablet

Enzyme Types
PARP (Poly ADP-Ribose Polymerase) inhibitor

Feature
Oral administration, high purity formulation

Ingredients
Rucaparib and excipients

Application
Anticancer therapy

Physical Color/Texture
Light blue, film-coated tablet

Enzymatic Activity
PARP inhibition

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
24 months

Registration
As per local regulatory authority

Packaging Size
Each strip contains 6 tablets

Route of Administration
Oral

Brand Name
Brand varies by manufacturer

Shape
Oval (bi-convex)

Prescription Status
Prescription only

Rucaparib 300 mg Tablets Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Rucaparib 300 mg Tablets About

Rucaparib 300 mg Tablets, an in-demand and commanding innovation in oncology, offer unassailable value in managing ovarian and select other cancers. As an opulent PARP inhibitor, each light blue, film-coated, oval (bi-convex) tablet contains highly pure Rucaparib and quality excipients. With its ephemeral shelf life of 24 months, this prescription-only medication is meticulously crafted for oral administration and registered as per local regulatory authority standards. Available in secure strips of 6, it delivers targeted anticancer therapy that patients and clinicians can trust, reflecting both efficacy and regulatory compliance.

Clinical Application & Directions for Rucaparib 300 mg Tablets

Rucaparib 300 mg Tablets are primarily used for the treatment of ovarian cancer and certain other malignancies as prescribed by healthcare professionals. Directions for use involve oral administration of one film-coated tablet, as directed by the oncologist, typically with or without food. This advanced medication functions through effective PARP inhibition, thereby impeding cancer cell growth. Used as part of comprehensive anticancer therapy, it integrates seamlessly into modern oncological regimens under guided supervision.

Supply Details, Domestic Market & Credentials for Rucaparib 300 mg Tablets

Rucaparib 300 mg Tablets are shipped across India by reputed suppliers and traders, with estimated supply abilities aligning with national demand. Sale price and order fulfillment depend on current market conditions and quantity requirements. The product is supported by certifications compliant with local regulatory authorities, ensuring consistent quality and reliability. Whether for hospital procurement or pharmacy restocking, these tablets maintain rigorous standards across major domestic markets, arriving securely and promptly to uphold therapeutic continuity.

FAQ's of Rucaparib 300 mg Tablets:

Q: How should Rucaparib 300 mg Tablets be administered?

A: Rucaparib 300 mg Tablets should be taken orally, following the exact dosage and schedule prescribed by your oncologist. Always swallow the tablet whole with water and avoid crushing or chewing it unless otherwise advised by your healthcare provider.

Q: What is the main benefit of using Rucaparib 300 mg Tablets?

A: The main benefit of Rucaparib 300 mg Tablets lies in their targeted action as PARP inhibitors, which help impede the growth of certain cancer cells, offering advanced therapeutic value in ovarian cancer and select related conditions.

Q: When is Rucaparib 300 mg Tablets typically prescribed?

A: This medication is prescribed when patients are diagnosed with ovarian cancer or specific other cancers, usually after evaluating individual case requirements and in accordance with current medical guidelines.

Q: Where can Rucaparib 300 mg Tablets be procured?

A: You can obtain Rucaparib 300 mg Tablets through licensed suppliers or pharmacies in India, provided you have a valid prescription from a certified healthcare professional.